Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics, Inc. (ANIK) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $12.85, down 0.54% on the day, which values the company at $172.13M. Price as of 18 Nov 2026, 12:28 UTC, from Yahoo Finance.

Key facts

Share price
$12.85−0.54% today
Market value
$172.13M
Forward P/E
12.8×
Funk Score
41/100
Against its own history
Below its usual priceusual price $18.27
200-week average
$18.8932% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Anika Therapeutics, Inc. in more detail

ANIK trades at 12.8× next year's expected earnings, 1.4× sales. Measured against its own history, the price is 30% below what its usual multiples would imply ($18.27) — below its usual price. It sits 32% below its 200-week average of $18.89.

Over the last five fiscal years Anika Therapeutics, Inc. has compounded revenue -2.9% a year, free cash flow -17.5% a year. Its Funk Score is 41 out of 100 (financial strength 7.3, profitability 1.4, growth 1.3, value 6.6, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt.

Anika Therapeutics, Inc. (ANIK): questions and answers

What is ANIK's PEG ratio?

Anika Therapeutics, Inc.'s PEG ratio is 1.29 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Anika Therapeutics, Inc.'s market cap?

Anika Therapeutics, Inc. is valued at $172.13M at a share price of $12.85.

Is ANIK overvalued or undervalued?

Against its own history, ANIK is below its usual price: the price is 30% below the $18.27 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ANIK above its 200-week moving average?

No. ANIK is 32.0% below its 200-week average of $18.89. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Anika Therapeutics, Inc. growing?

Over the last five fiscal years Anika Therapeutics, Inc.'s revenue grew -2.9% a year; over ten years revenue grew 2.0% a year.

Does ANIK pay a dividend?

Anika Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Anika Therapeutics, Inc. (ANIK) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/ANIK

Underlying data: Yahoo Finance; company filings with the SEC.